Related Experiment Videos
Physiological assessment of complex cardiac phenotypes in genetically engineered mice
G Christensen1, Y Wang, K R Chien
1Department of Medicine, University of California, San Diego, School of Medicine, La Jolla 92093, USA.
The American Journal of Physiology
|June 1, 1997
Summary
Genetically engineered mouse models are advancing the study of human heart disease. New techniques allow detailed analysis of cardiac physiology and disease mechanisms, guiding future therapies.
Area of Science:
- Cardiovascular Research
- Translational Medicine
- Animal Models
Background:
- Human heart disease, including congenital and acquired forms, presents complex challenges.
- Cardiac overload is a key factor in the development of hypertrophy and heart failure.
- Understanding disease mechanisms requires robust experimental models.
Purpose of the Study:
- To review recent advances in studying cardiac disease using mouse models.
- To highlight techniques for assessing cardiac physiology and disease in mice.
- To discuss the utility of mouse models for understanding human heart conditions.
Main Methods:
- Development and characterization of mouse models for cardiac pressure/volume overload and ischemia.
- In vivo assessment of murine cardiac physiology using microtransducers and echocardiography.
- In vitro analysis of single cardiomyocyte phenotypes from genetically engineered mice.
Main Results:
- Successful characterization of gene-targeted and transgenic mouse models for hypertrophy, dilated cardiomyopathy, and developmental defects.
- Integration of physiological assessments with histology and molecular markers.
- Validation of mouse models for studying cardiac disease mechanisms.
Conclusions:
- Mouse models are crucial for dissecting the molecular basis of heart disease.
- These models facilitate the development of targeted therapeutic strategies for human cardiovascular conditions.
- Advances in mouse cardiac research offer significant promise for improving patient outcomes.